Related Experiment Video
Updated: Feb 20, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Opinion and Knowledge of Pulmonologists, Primary Care Physicians, and Nurses About Inhaled Therapy in COPD.
Javier De Miguel-Díez1, Jordi Giner Donaire2, José Tomas Gómez Sáenz3
1Pulmonology Service, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.
Purpose:
Despite the efforts made to improve inhalation technique by both patients and healthcare professionals, significant deficiencies were found in critical aspects of inhaler use and device selection. The aim of this study is to know the current opinion and knowledge of pulmonologists, primary care physicians, and nurses about inhaled therapy in chronic obstructive pulmonary disease (COPD).
Methods:
Survey conducted between April-July 2023 by a committee of experts formed by 2 pulmonologists, 2 primary care physicians, and one nurse specialist in inhaled therapy. It consisted of 27 questions and was sent by e-mail to professionals throughout Spain with experience in the management of COPD with inhaled therapy.
Results:
A total of 554 experts from all over Spain participated. Thirty-one percent and 43.5% of the respondents could not identify, respectively, which were the critical steps for correct inhalation of the pressurized metered-dose inhaler (pMDI) and the multidose dry powder inhaler (DPI). Conventional pMDIs were considered to be the devices that provide greater oropharyngeal deposition and less pulmonary deposition. The majority of respondents considered essential or important to take into account the patients' opinion in selecting the inhaler, and preferred to review the inhalation technique rather than change the device. The main criteria for the choice of inhaler in COPD patients were their previous experience, preference, and severity. With a wide dispersion of results, Ellypta®, pMDI with chamber, Genuair®, Respimat®, and conventional pMDI were preferred in that order.
Conclusion:
Knowledge about inhaled therapy in COPD remains insufficient. There is a significant and important lack of knowledge in key aspects of the use of inhaler devices, such as the critical steps for correct inhalation and the selection criteria for inhalation devices. It is necessary to continue promoting training programs for both patients and healthcare personnel in inhalers and inhalation techniques.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Inhaled Medications
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

